Chem. J. Chinese Universities ›› 2011, Vol. 32 ›› Issue (6): 1295.

• Articles • Previous Articles     Next Articles

125I-AIBZM Nanoliposomes  Targeting Brain as Imaging Agents

LI Guang-Hui, SHEN Hai-Xing, QIAN Jun, SI Zhan, ZHU Jian-Hua*   

  1. Department of Radiopharmacy, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education & PLA, Shanghai 201203, China
  • Received:2010-10-28 Revised:2010-12-22 Online:2011-06-10 Published:2011-05-10
  • Contact: ZHU Jian-Hua E-mail:jhzhu@shmu.edu.cn
  • Supported by:

    国家“九七三”计划项目(批准号: 2007CB935800)资助.

Abstract: The aim of this study is to develop a blood brain barrier (BBB) permeable nano-liposome drug delivery system that significantly up-regulates the brain uptake of (S)-5-125I-N-(1-ethyl-2-pyrrolidinyl)methyl-4-amine-2-methoxy-benzamide (125I-AIBZM) as an imaging agent. Both 125I-AIBZM-nanoliposome (125I-AIBZM-L) and 125I-AIBZM-lactoferrin-nanoliposome (125I-AIBZM-Lf-L) were prepared by the ammonium sulfate gradient method with a small particle size (~100 nm) and a narrow size distribution pattern. The encapsulation efficiencies of 125I-AIBZM-L and 125I-AIBZM-Lf-L were measured as 39% and 35% respectively. In vivo fluorescence imaging results showed that DIR-Lf-L successfully delivered drug into the brain. The pharmacokinetic experiments in rats indicated that the blood circulation times of 125I-AIBZM-L and 125I-AIBZM-Lf-L were substantially longer than that of small molecular 125I-AIBZM. Amount of intracerebral 125I-AIBZM delivered by 125I-AIBZM-L was significantly lower than 125I-AIBZM-Lf-L (p <0.01) but remarkably higher than that of 125I-AIBZM (p <0.01). Conclusion: 125I-AIBZM-Lf-L nano-liposome drug delivery system can increase the brain uptake of imaging agent 125I-AIBZM.

Key words: 125I, Dopamine D2 receptor, Lactoferrin, liposome, In vivo fluorescence imaging

CLC Number: 

TrendMD: